Laetrile: An Unproven Cancer Treatment
Theories on Laetrile
Current Use of Laetrile
The Dangers of Taking Laetrile
- Nausea and vomiting
- Bluish skin color
- Liver damage
- Droopy eyelids
- Trouble walking
American Cancer Society http://www.cancer.org
Food and Drug Administration http://www.fda.gov
Canadian Cancer Society http://www.cancer.ca
Health Canada http://www.hc-sc.gc.ca
Beware of online cancer fraud. US Food and Drug Administration website. Available at: http://www.fda.gov/forconsumers/consumerupdates/ucm048383.htm. Updated September 18, 2008. Accessed July 23, 2015.
Import alert 62-01. US Food and Drug Administration website. Available at: http://www.accessdata.fda.gov/cms%5Fia/importalert%5F167.html. Published March 18, 2011. Accessed July 23, 2015.
Laetrile/amygdalin—for health professionals (PDQ®). National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/pdq/cam/laetrile/HealthProfessional/page2. Updated March 26, 2015. Accessed July 23, 2015.
Milazzo S, Ernst E, et al. Laetrile treatment for cancer. Cochrane Database Syst Rev. 2011;(11):CD005476.
Milazzo S, Lejeune S, et al. Laetrile for cancer: a systematic review of the clinical evidence. Support Care Cancer. 2007;15(6):583-595.
- Reviewer: Michael Woods, MD
- Review Date: 07/2015 -
- Update Date: 10/15/2013 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.